Preclinical Development and a Case Report of a Nanobody-Based CLDN18.2 CAR-T IMC002 with Reduced On-Target Off-Tumor Toxicity
1. 系统已在2026-08-10 10:56:07对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1158/1535-7163.MCT-25-0171
文献链接: https://aacrjournals.org/mct/article/25/5/701/784434/Preclinical-Development-and-a-Case-Report-of-a
其他信息:
出版社: American Association for Cancer Research (AACR)
作者: Sicheng Du; Ying Zhang; Ruidong Hao; Lupeng Qiu; Chao Li; Yuting Li; Rong-Rui Liu; Chuan-Hua Zhao; Juan Li; Sisi Ye; Jun Zhou; Yantao Li; Qiaoyong Yi; Shuangshuang Zhang; Minmin Sun; Tianhang Luo; Jianming Xu
全文下载地址: https://aacrjournals.org/mct/article-pdf/doi/10.1158/1535-7163.MCT-25-0171/3669865/mct-25-0171.pdf
